RJG-2051

Overview

RJG-2051 is a selective covalent aldo-keto reductase family 1 member C3 ( AKR1C3 ) inhibitor with an IC 50 value of 13 nM. RJG-2051 interferes with the metabolic process of substrates such as androgens, estrogens, and prostaglandins by AKR1C3. RJG-2051 is promising for research of cancers.

Application

Products | Products > Disease Areas > Cancer | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy

Product Information

• Catalog No.: HY-176084
• CAS No.: 2851993-77-4
• Molecular Formula: C26H31N5O4S
• Molecular Weight: 509.62
• Purity: 99.42%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.91 mM); Clear solution
• Availability: In-stock

Source

Original product source